Trial intelligence / Profile preview

Gabapentin Premedication for Postoperative Pain in Neurosurgery

NCT02306278Completed

Sponsor
Capital Medical University
Start
Dec 2014
Primary completion
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in postoperative pain and postoperative nausea and vomiting (PONV) comparing Gabapentin Group with Placebo Group (2 arms). Primary endpoint: Postoperative Pain (VAS) at 24 hours. Started Dec 2014; status: completed.

02

Drugs

gabapentin
03

Conditions

postoperative painpostoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on NCT02306278.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02306278.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call